Novo Nordisk
NVO
NVO
484 hedge funds and large institutions have $6.59B invested in Novo Nordisk in 2017 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 149 increasing their positions, 176 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 463 → 484 (+21)
0.35% less ownership
Funds ownership: 16.02% → 15.67% (-0.35%)
15% less repeat investments, than reductions
Existing positions increased: 149 | Existing positions reduced: 176
Holders
484
Holding in Top 10
11
Calls
$45.5M
Puts
$30.1M
Top Buyers
| 1 | +$57.1M | |
| 2 | +$45.4M | |
| 3 | +$34.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$25.7M |
| 5 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$24.2M |
Top Sellers
| 1 | -$123M | |
| 2 | -$82.7M | |
| 3 | -$72.6M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$48.1M |
| 5 |
Two Sigma Advisers
New York
|
-$44.7M |